SCHEMBL1835975

SCHEMBL1835975

CC(C)C[C@H](NC(=O)Oc1ccccc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MME P08473 3/20 0.52
SLC1A3 P43003 1/20 0.51
ALDH1A1 P00352 1/20 0.50
LTA4H P09960 1/20 0.50
CTSK P43235 2/20 0.49
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5258106 1.00 MME (0.52) MMESLC1A3ALDH1A1LTA4HCTSK
SCHEMBL23423133 0.88 BIRC2 (0.51) CTSK
SCHEMBL8139330 0.85 CYP1A2 (0.50) SLC1A3CTSKGAA
SCHEMBL8604298 0.84 CYP1A2 (0.57) MMESLC1A3ALDH1A1GAA
SCHEMBL16124612 0.83 MAPT (0.54) MMEALDH1A1
SCHEMBL1835785 0.82 SLC1A3 (0.47) SLC1A3ALDH1A1GAA
SCHEMBL1835782 0.82 SLC1A3 (0.47) SLC1A3ALDH1A1GAA
SCHEMBL2747500 0.82 MGLL (0.51) ALDH1A1GAA
SCHEMBL5262303 0.82 SLC1A3 (0.55) MMESLC1A3ALDH1A1GAA
SCHEMBL5262300 0.82 SLC1A3 (0.55) MMESLC1A3ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110546135-B Method for producing isocyanate 旭化成株式会社 2021-12-14 CN disclosed
CN-112438905-B Moisturizing and skin-brightening composition and application thereof 澳思美日用化工(广州)有限公司 2021-09-07 CN disclosed
CN-112438905-A Moisturizing and skin-brightening composition and application thereof 澳思美日用化工(广州)有限公司 2021-03-05 CN disclosed
CN-110546135-A Method for producing isocyanate ASAHI CHEMICAL IND 2019-12-06 CN disclosed
EP-2322515-B1 A process for the preparation of an N-carboxy amino acid anhydride or an amino acid carbamate JSR CORP (JP) 2016-04-20 EP disclosed
US-9260460-B2 Organogold complexes and methods for making the same THE UNIVERSITY OF SUSSEX (GB) 2016-02-16 US disclosed
US-8748650-B2 Method for production of N-carboxy amino acid anhydride and amino acid carbamate compound JSR CORPORATION (JP) 2014-06-10 US disclosed
US-20140039200-A1 ORGANOGOLD COMPLEXES AND METHODS FOR MAKING THE SAME THE UNIVERSITY OF SUSSEX (GB) 2014-02-06 US disclosed
EP-2691400-A1 ORGANOGOLD COMPLEXES AND METHODS FOR MAKING THE SAME The University of Sussex (GB) 2014-02-05 EP disclosed
WO-2012131313-A1 ORGANOGOLD COMPLEXES AND METHODS FOR MAKING THE SAME THE UNIVERSITY OF SUSSEX (GB) 2012-10-04 WO disclosed
US-8178641-B2 Amino group-containing conjugated diene polymer and method for producing the same, and block copolymer and method for producing the same JSR CORPORATION (JP) 2012-05-15 US disclosed
US-20110152561-A1 METHOD FOR PRODUCTION OF N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND JSR CORPORATION (JP) 2011-06-23 US disclosed
EP-2322515-A1 N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND PRODUCTION METHOD JSR Corporation (JP) 2011-05-18 EP disclosed
US-20100267918-A1 AMINO GROUP-CONTAINING CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING THE SAME, AND BLOCK COPOLYMER AND METHOD FOR PRODUCING THE SAME JSR CORPORATION (JP) 2010-10-21 US disclosed
EP-1338588-B1 METHOD OF RESOLVING OPTICAL ISOMERS OF AMINO ACID DERIVATIVE TOKUYAMA CORP (JP) 2007-09-26 EP disclosed
US-7199264-B2 Method of resolving optical isomers of amino acid derivative TOKUYAMA CORPORATION (JP) 2007-04-03 US disclosed
US-20040102646-A1 Method of resolving optical isomers of amino acid derivative TOKUYAMA CORPORATION (JP) 2004-05-27 US disclosed
EP-1338588-A1 METHOD OF RESOLVING OPTICAL ISOMERS OF AMINO ACID DERIVATIVE TOKUYAMA CORPORATION (JP) 2003-08-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102646-A1 Method of resolving optical isomers of amino acid derivative ALAD, AAAS, BCAT1 MME 1298/4885SLC1A3 105/4885ALDH1A1 3448/4885
US-20110152561-A1 METHOD FOR PRODUCTION OF N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND CA7, CPS1, DNPEP MME 405/4885SLC1A3 73/4885ALDH1A1 3310/4885
US-20140039200-A1 ORGANOGOLD COMPLEXES AND METHODS FOR MAKING THE SAME BCAT1, BCAT2, SPR MME 1005/4885SLC1A3 107/4885ALDH1A1 668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.